These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drug treatment of gout. Kelley WN; Wyngaarden JB Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305 [No Abstract] [Full Text] [Related]
23. [Gout (pathogenesis and therapy)]. Chirone E Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779 [No Abstract] [Full Text] [Related]
24. The current state of care in gout: Addressing the need for better understanding of an ancient disease. Zychowicz ME; Pope RS; Graser E J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636 [TBL] [Abstract][Full Text] [Related]
26. Gout in women. McClory J; Said N Med Health R I; 2009 Nov; 92(11):363-4, 368. PubMed ID: 19999895 [No Abstract] [Full Text] [Related]
27. The treatment of hyperuricemia in gout. Rastegar A; Thier SO Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829 [No Abstract] [Full Text] [Related]
28. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone]. Mugler A Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166 [No Abstract] [Full Text] [Related]
29. Uricosuric effect of irtemazole in hyperuricemic patients without and with renal insufficiency. Kamilli I; Gresser U; Pellkofer T; Löffler W; Zöllner N Z Rheumatol; 1989; 48(6):307-12. PubMed ID: 2623976 [TBL] [Abstract][Full Text] [Related]
30. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice]. Cottin S; Prost A Sem Hop; 1972 May; 48(24):1739-42. PubMed ID: 4340887 [No Abstract] [Full Text] [Related]
31. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents]. Delbarre F; Saporta L; de Géry A; Jabre E Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852 [No Abstract] [Full Text] [Related]
32. [Benziodarone therapy in hyperuricemia in the aged]. Ravera M; Ugo C G Gerontol; 1970 Sep; 18(9):876-9. PubMed ID: 5517231 [No Abstract] [Full Text] [Related]
33. [Gout]. Radi I Schweiz Med Wochenschr; 1970 Feb; 100(8):383-6. PubMed ID: 4946973 [No Abstract] [Full Text] [Related]
35. [Use of sorption for the correction of hyperuricemia in the combined treatment of gout]. Matulis AA; Bareĭkene IP; Venalis AI Ter Arkh; 1987; 59(12):17-9. PubMed ID: 3447284 [No Abstract] [Full Text] [Related]
36. [Benziodarone in the basic treatment of gout]. Ryckewaert A; Puel M; Kuntz D Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688 [No Abstract] [Full Text] [Related]
37. [Clinical trial of L2214 in the treatment of gout or of rheumatologic syndromes associated with hyperuricemia]. van Bogaert P J Belge Rhumatol Med Phys; 1969; 24(6):295-315. PubMed ID: 5403086 [No Abstract] [Full Text] [Related]
38. Drugs for gout. Med Lett Drugs Ther; 2014 Mar; 56(1438):22-4. PubMed ID: 24791281 [No Abstract] [Full Text] [Related]
39. [The internal therapy of patients with uric acid containing urinary calculi]. Zöllner N Urologe; 1968; 7(1):46-50. PubMed ID: 5667553 [No Abstract] [Full Text] [Related]
40. [Diagnosis and therapy of gout and hyperuricemia]. Guzmán L Rev Med Chil; 1981 Dec; 109(12):1191-7. PubMed ID: 7346920 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]